Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR‐625 and miR‐892b

Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic ductal adenocarcinoma (PDAC). Recently, circ_0007534 has been identified as a novel cancer‐related circRNA. Nevertheless, its clinical relev...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular biochemistry Vol. 120; no. 3; pp. 3780 - 3789
Main Authors Hao, Liguo, Rong, Wei, Bai, Lianjie, Cui, Hongsheng, Zhang, Shuli, Li, Yuanchun, Chen, Datong, Meng, Xin
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic ductal adenocarcinoma (PDAC). Recently, circ_0007534 has been identified as a novel cancer‐related circRNA. Nevertheless, its clinical relevance, functional roles, and mechanism have not been studied in PDAC. In the current study, real‐time quantitative polymerase chain reaction (RT‐qPCR) was used to detect the expression of circ_0007534 in 60‐paired PDAC tissue samples and different cell lines. Loss‐of‐function and gain‐of‐function assays were performed to detect cell proliferation, apoptosis, and metastatic properties affected by circ_0007534. An animal study was also carried out. The luciferase reporter assay was performed to uncover the underlying mechanism of circ_0007534. As a result, circ_0007534 was overexpressed not only in PDAC tissues but also in a panel of PDAC cell lines, and this overexpression is closely associated with advanced tumor stage and positive lymph node invasion. In addition, circ_0007534 may be regarded as an independent prognostic factor for patients with PDAC. For the part of functional assays, circ_0007534 significantly increased cell proliferation, migratory, and invasive potential of PDAC cells. Circ_0007534 could inhibit cell apoptosis partly via a Bcl‐2/caspase‐3 pathway. The xenograft study further confirmed the cell growth promoting the role of circ_0007534. Mechanistically, miR‐625 and miR‐892b were sponged by circ_0007534. The oncogenic functions of circ_0007534 is partly dependent on its regulation of miR‐625 and miR‐892b. In conclusion, our study illuminates a novel circRNA that confers an oncogenic function in PDAC. Circ_0007534 is upregulated in pancreatic ductal adenocarcinoma (PDAC) both in tissues and cells. Circ_0007534 is associated with patients’ adverse phenotypes and poor survival. The circ_0007534/miR‐625/miR‐892 regulatory axis may contribute to the carcinogenesis and development of PDAC.
AbstractList Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic ductal adenocarcinoma (PDAC). Recently, circ_0007534 has been identified as a novel cancer‐related circRNA. Nevertheless, its clinical relevance, functional roles, and mechanism have not been studied in PDAC. In the current study, real‐time quantitative polymerase chain reaction (RT‐qPCR) was used to detect the expression of circ_0007534 in 60‐paired PDAC tissue samples and different cell lines. Loss‐of‐function and gain‐of‐function assays were performed to detect cell proliferation, apoptosis, and metastatic properties affected by circ_0007534. An animal study was also carried out. The luciferase reporter assay was performed to uncover the underlying mechanism of circ_0007534. As a result, circ_0007534 was overexpressed not only in PDAC tissues but also in a panel of PDAC cell lines, and this overexpression is closely associated with advanced tumor stage and positive lymph node invasion. In addition, circ_0007534 may be regarded as an independent prognostic factor for patients with PDAC. For the part of functional assays, circ_0007534 significantly increased cell proliferation, migratory, and invasive potential of PDAC cells. Circ_0007534 could inhibit cell apoptosis partly via a Bcl‐2/caspase‐3 pathway. The xenograft study further confirmed the cell growth promoting the role of circ_0007534. Mechanistically, miR‐625 and miR‐892b were sponged by circ_0007534. The oncogenic functions of circ_0007534 is partly dependent on its regulation of miR‐625 and miR‐892b. In conclusion, our study illuminates a novel circRNA that confers an oncogenic function in PDAC.
Abstract Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic ductal adenocarcinoma (PDAC). Recently, circ_0007534 has been identified as a novel cancer‐related circRNA. Nevertheless, its clinical relevance, functional roles, and mechanism have not been studied in PDAC. In the current study, real‐time quantitative polymerase chain reaction (RT‐qPCR) was used to detect the expression of circ_0007534 in 60‐paired PDAC tissue samples and different cell lines. Loss‐of‐function and gain‐of‐function assays were performed to detect cell proliferation, apoptosis, and metastatic properties affected by circ_0007534. An animal study was also carried out. The luciferase reporter assay was performed to uncover the underlying mechanism of circ_0007534. As a result, circ_0007534 was overexpressed not only in PDAC tissues but also in a panel of PDAC cell lines, and this overexpression is closely associated with advanced tumor stage and positive lymph node invasion. In addition, circ_0007534 may be regarded as an independent prognostic factor for patients with PDAC. For the part of functional assays, circ_0007534 significantly increased cell proliferation, migratory, and invasive potential of PDAC cells. Circ_0007534 could inhibit cell apoptosis partly via a Bcl‐2/caspase‐3 pathway. The xenograft study further confirmed the cell growth promoting the role of circ_0007534. Mechanistically, miR‐625 and miR‐892b were sponged by circ_0007534. The oncogenic functions of circ_0007534 is partly dependent on its regulation of miR‐625 and miR‐892b. In conclusion, our study illuminates a novel circRNA that confers an oncogenic function in PDAC.
Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic ductal adenocarcinoma (PDAC). Recently, circ_0007534 has been identified as a novel cancer-related circRNA. Nevertheless, its clinical relevance, functional roles, and mechanism have not been studied in PDAC. In the current study, real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression of circ_0007534 in 60-paired PDAC tissue samples and different cell lines. Loss-of-function and gain-of-function assays were performed to detect cell proliferation, apoptosis, and metastatic properties affected by circ_0007534. An animal study was also carried out. The luciferase reporter assay was performed to uncover the underlying mechanism of circ_0007534. As a result, circ_0007534 was overexpressed not only in PDAC tissues but also in a panel of PDAC cell lines, and this overexpression is closely associated with advanced tumor stage and positive lymph node invasion. In addition, circ_0007534 may be regarded as an independent prognostic factor for patients with PDAC. For the part of functional assays, circ_0007534 significantly increased cell proliferation, migratory, and invasive potential of PDAC cells. Circ_0007534 could inhibit cell apoptosis partly via a Bcl-2/caspase-3 pathway. The xenograft study further confirmed the cell growth promoting the role of circ_0007534. Mechanistically, miR-625 and miR-892b were sponged by circ_0007534. The oncogenic functions of circ_0007534 is partly dependent on its regulation of miR-625 and miR-892b. In conclusion, our study illuminates a novel circRNA that confers an oncogenic function in PDAC.
Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic ductal adenocarcinoma (PDAC). Recently, circ_0007534 has been identified as a novel cancer‐related circRNA. Nevertheless, its clinical relevance, functional roles, and mechanism have not been studied in PDAC. In the current study, real‐time quantitative polymerase chain reaction (RT‐qPCR) was used to detect the expression of circ_0007534 in 60‐paired PDAC tissue samples and different cell lines. Loss‐of‐function and gain‐of‐function assays were performed to detect cell proliferation, apoptosis, and metastatic properties affected by circ_0007534. An animal study was also carried out. The luciferase reporter assay was performed to uncover the underlying mechanism of circ_0007534. As a result, circ_0007534 was overexpressed not only in PDAC tissues but also in a panel of PDAC cell lines, and this overexpression is closely associated with advanced tumor stage and positive lymph node invasion. In addition, circ_0007534 may be regarded as an independent prognostic factor for patients with PDAC. For the part of functional assays, circ_0007534 significantly increased cell proliferation, migratory, and invasive potential of PDAC cells. Circ_0007534 could inhibit cell apoptosis partly via a Bcl‐2/caspase‐3 pathway. The xenograft study further confirmed the cell growth promoting the role of circ_0007534. Mechanistically, miR‐625 and miR‐892b were sponged by circ_0007534. The oncogenic functions of circ_0007534 is partly dependent on its regulation of miR‐625 and miR‐892b. In conclusion, our study illuminates a novel circRNA that confers an oncogenic function in PDAC. Circ_0007534 is upregulated in pancreatic ductal adenocarcinoma (PDAC) both in tissues and cells. Circ_0007534 is associated with patients’ adverse phenotypes and poor survival. The circ_0007534/miR‐625/miR‐892 regulatory axis may contribute to the carcinogenesis and development of PDAC.
Author Meng, Xin
Cui, Hongsheng
Bai, Lianjie
Li, Yuanchun
Chen, Datong
Rong, Wei
Zhang, Shuli
Hao, Liguo
Author_xml – sequence: 1
  givenname: Liguo
  orcidid: 0000-0003-2677-180X
  surname: Hao
  fullname: Hao, Liguo
  email: hlg2018@sina.com
  organization: Medical Technology Academy, Qiqihar Medical University
– sequence: 2
  givenname: Wei
  surname: Rong
  fullname: Rong, Wei
  organization: Micromorphology Research Center, Medical Pathology Academy, Qiqihar Medical University
– sequence: 3
  givenname: Lianjie
  surname: Bai
  fullname: Bai, Lianjie
  organization: The Second Affiliated Hospital of Qiqihar Medical University
– sequence: 4
  givenname: Hongsheng
  surname: Cui
  fullname: Cui, Hongsheng
  organization: The Third Affiliated Hospital of Qiqihar Medical University
– sequence: 5
  givenname: Shuli
  surname: Zhang
  fullname: Zhang, Shuli
  organization: Medical Technology Academy, Qiqihar Medical University
– sequence: 6
  givenname: Yuanchun
  surname: Li
  fullname: Li, Yuanchun
  organization: The Second Affiliated Hospital of Qiqihar Medical University
– sequence: 7
  givenname: Datong
  surname: Chen
  fullname: Chen, Datong
  organization: Medical Technology Academy, Qiqihar Medical University
– sequence: 8
  givenname: Xin
  surname: Meng
  fullname: Meng, Xin
  organization: The Third Affiliated Hospital of Qiqihar Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30382592$$D View this record in MEDLINE/PubMed
BookMark eNp1kctu1DAUhi1URKeFBS-ALLEBqWl9iR17WUblpgqkiq6jE8cZeZSxg50UzY5H6HvxFjwJzqRlgcTKPjrf-Xys_wQd-eAtQi8pOaeEsIutac5ZJYV6glaU6KooZVkeoRWpOCkYp-wYnaS0JYRozdkzdMwJV0xotkK_bodoN1MPo22xcdHka8Q3Xy4PRZ1HKsFL7HzrTGYSBo8n38FdiND0Fg8xbHxILmUED-BNtDA6g9vJjNBjaK0PBqJxPuwgD7f48bmEje37WdC7zsY8FfwZhiEM4-w7O8DO30HKDdzscRqC3zi_wTt38_vnvWTigCyV0qx5jp520Cf74uE8Rbfvr76tPxbXXz98Wl9eF6akWhWKiEYaEBS0ZIw3ouXQEC2VUkANbwVnqiWMcyIrUFQaQ4QUFZGd7UDl9il6s3jz7t8nm8Z659L8GfA2TKlmlFVaMKpURl__g27DFH3eLlOyIkJUeqbeLpSJIaVou3qIbgdxX1NSzwnXOeH6kHBmXz0Yp2Zn27_kY6QZuFiAH663-_-b6s_rd4vyD8CxtD8
CitedBy_id crossref_primary_10_1016_j_lfs_2019_116785
crossref_primary_10_1038_s41420_023_01733_2
crossref_primary_10_1016_j_bbrc_2019_04_017
crossref_primary_10_1007_s10571_021_01150_y
crossref_primary_10_3389_fphar_2019_00428
crossref_primary_10_1016_j_hbpd_2019_09_009
crossref_primary_10_1002_cam4_2384
crossref_primary_10_3389_fonc_2022_1031802
crossref_primary_10_1136_gutjnl_2019_318279
crossref_primary_10_1002_jcb_28863
crossref_primary_10_1186_s12935_021_01749_7
crossref_primary_10_1002_jcb_28820
crossref_primary_10_1002_jcb_28224
crossref_primary_10_3389_fcell_2022_1023332
crossref_primary_10_3389_fonc_2022_985470
crossref_primary_10_1007_s10528_023_10448_z
crossref_primary_10_3389_fcell_2020_570305
crossref_primary_10_1002_jcb_28822
crossref_primary_10_1007_s12033_023_00865_1
crossref_primary_10_1080_15384101_2021_2020450
crossref_primary_10_1016_j_jbo_2021_100349
crossref_primary_10_1080_13880209_2022_2032206
crossref_primary_10_1016_j_semcancer_2020_11_004
crossref_primary_10_1002_jcb_29245
crossref_primary_10_1097_JP9_0000000000000087
crossref_primary_10_3390_cancers12113250
crossref_primary_10_2174_1568009619666191107140948
crossref_primary_10_1002_jcb_28313
crossref_primary_10_1002_jcb_28795
crossref_primary_10_1016_j_critrevonc_2019_102854
crossref_primary_10_3390_biomedicines9111642
crossref_primary_10_1016_j_semcancer_2020_10_001
crossref_primary_10_1186_s12864_019_6032_3
crossref_primary_10_4236_ijcm_2020_1110052
crossref_primary_10_3389_fonc_2021_675442
crossref_primary_10_1002_jcb_28916
crossref_primary_10_1002_jcp_29754
crossref_primary_10_1007_s11011_022_00906_9
crossref_primary_10_1016_j_tranon_2021_101090
crossref_primary_10_3389_fonc_2023_1174577
crossref_primary_10_12998_wjcc_v9_i34_10400
crossref_primary_10_3390_cancers13164161
crossref_primary_10_3892_ol_2021_13174
crossref_primary_10_3389_fonc_2020_00309
crossref_primary_10_2217_bmm_2020_0750
crossref_primary_10_3389_fmicb_2020_01853
crossref_primary_10_1016_j_pan_2020_12_023
crossref_primary_10_1097_MPA_0000000000002342
crossref_primary_10_1631_jzus_B1900468
crossref_primary_10_3390_jpm11020127
crossref_primary_10_1016_j_prp_2020_153075
crossref_primary_10_1093_toxres_tfad032
crossref_primary_10_1016_j_bbrep_2022_101289
crossref_primary_10_1097_MD_0000000000017488
crossref_primary_10_1111_jcmm_15572
crossref_primary_10_1016_j_pharmthera_2021_107869
crossref_primary_10_32604_oncologie_2021_018514
crossref_primary_10_1007_s13273_021_00172_3
crossref_primary_10_1016_j_omtn_2019_12_028
crossref_primary_10_3390_cancers14246187
crossref_primary_10_1080_15384047_2019_1617563
crossref_primary_10_1038_s41419_021_03495_0
crossref_primary_10_2147_CMAR_S255808
crossref_primary_10_1016_j_lfs_2019_116871
crossref_primary_10_1093_carcin_bgaa130
crossref_primary_10_2147_CMAR_S308809
crossref_primary_10_1186_s13578_022_00833_3
crossref_primary_10_18632_aging_101872
crossref_primary_10_1002_jcb_28411
crossref_primary_10_1515_biol_2021_0047
crossref_primary_10_1016_j_prp_2022_153833
crossref_primary_10_1016_j_cca_2023_117633
crossref_primary_10_1002_jcla_23359
crossref_primary_10_1186_s13046_021_01910_0
crossref_primary_10_3389_fcell_2023_1226639
crossref_primary_10_3233_CBM_190908
crossref_primary_10_3389_fmed_2022_845094
Cites_doi 10.1056/NEJMra1404198
10.1247/csf.18005
10.3892/or.2016.5052
10.1038/nrgastro.2012.119
10.1016/S0140-6736(04)15841-8
10.1002/wrna.1463
10.1158/0008-5472.CAN-15-1770
10.1016/j.bbrc.2018.03.219
10.1016/j.bbcan.2018.06.002
10.1186/1741-7015-10-39
10.1038/nature11928
10.1016/j.bbrc.2018.06.089
10.1016/j.canlet.2018.02.014
10.1159/000491468
10.5582/irdr.2018.01013
10.1016/j.bbrc.2018.05.174
10.2147/OTT.S150678
10.1261/rna.035667.112
10.18632/oncotarget.14710
10.1016/j.yexcr.2018.05.002
10.1002/jso.24623
10.3390/genes8120353
10.2147/OTT.S132558
10.1016/j.bbrc.2018.01.077
ContentType Journal Article
Copyright 2018 Wiley Periodicals, Inc.
2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2018 Wiley Periodicals, Inc.
– notice: 2019 Wiley Periodicals, Inc.
DBID NPM
AAYXX
CITATION
7QL
7QP
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1002/jcb.27658
DatabaseName PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Virology and AIDS Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts
CrossRef
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1097-4644
EndPage 3789
ExternalDocumentID 10_1002_jcb_27658
30382592
JCB27658
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: The Science Foundation of Qiqihar Medical University
  funderid: QY2016M‐06
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH6
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NDZJH
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RBB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V8K
W8V
W99
WBKPD
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WSB
WXSBR
WYISQ
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
NPM
AAYXX
CITATION
7QL
7QP
7QR
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c4198-805b6ca51a96223b5d3ab096888a1c3d5328d0233067a816cc0565706fefa8d53
IEDL.DBID DR2
ISSN 0730-2312
IngestDate Fri Aug 16 03:55:28 EDT 2024
Fri Sep 13 10:25:10 EDT 2024
Thu Aug 22 15:04:47 EDT 2024
Sat Sep 28 08:31:29 EDT 2024
Sat Aug 24 00:48:20 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords miR-892b
circ_0007534
circular RNA
miR-625
pancreatic ductal adenocarcinoma
Language English
License 2018 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4198-805b6ca51a96223b5d3ab096888a1c3d5328d0233067a816cc0565706fefa8d53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2677-180X
PMID 30382592
PQID 2167055798
PQPubID 1006368
PageCount 10
ParticipantIDs proquest_miscellaneous_2127952188
proquest_journals_2167055798
crossref_primary_10_1002_jcb_27658
pubmed_primary_30382592
wiley_primary_10_1002_jcb_27658_JCB27658
PublicationCentury 2000
PublicationDate March 2019
PublicationDateYYYYMMDD 2019-03-01
PublicationDate_xml – month: 03
  year: 2019
  text: March 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular biochemistry
PublicationTitleAlternate J Cell Biochem
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_7_1_10_1
e_1_2_7_1_11_1
e_1_2_7_1_12_1
e_1_2_7_1_13_1
Zhang R (e_1_2_7_1_14_1) 2018; 22
e_1_2_7_1_30_1
e_1_2_7_1_5_1
e_1_2_7_1_29_1
e_1_2_7_1_6_1
e_1_2_7_1_7_1
e_1_2_7_1_8_1
e_1_2_7_1_25_1
e_1_2_7_1_2_1
e_1_2_7_1_26_1
e_1_2_7_1_3_1
e_1_2_7_1_4_1
e_1_2_7_1_28_1
e_1_2_7_1_21_1
e_1_2_7_1_22_1
e_1_2_7_1_23_1
e_1_2_7_1_24_1
Zhang J (e_1_2_7_1_27_1) 2017; 7
e_1_2_7_1_9_1
e_1_2_7_1_20_1
Torrisani J (e_1_2_7_1_16_1) 2002; 22
e_1_2_7_1_18_1
e_1_2_7_1_19_1
e_1_2_7_1_15_1
e_1_2_7_1_17_1
References_xml – ident: e_1_2_7_1_3_1
  doi: 10.1056/NEJMra1404198
– ident: e_1_2_7_1_7_1
  doi: 10.1247/csf.18005
– ident: e_1_2_7_1_30_1
  doi: 10.3892/or.2016.5052
– ident: e_1_2_7_1_2_1
  doi: 10.1038/nrgastro.2012.119
– ident: e_1_2_7_1_15_1
  doi: 10.1016/S0140-6736(04)15841-8
– ident: e_1_2_7_1_20_1
  doi: 10.1002/wrna.1463
– volume: 22
  start-page: 349
  year: 2002
  ident: e_1_2_7_1_16_1
  article-title: Molecular pathways of pancreatic carcinogenesis
  publication-title: Ann Pathol
  contributor:
    fullname: Torrisani J
– ident: e_1_2_7_1_29_1
  doi: 10.1158/0008-5472.CAN-15-1770
– ident: e_1_2_7_1_13_1
  doi: 10.1016/j.bbrc.2018.03.219
– ident: e_1_2_7_1_22_1
  doi: 10.1016/j.bbcan.2018.06.002
– ident: e_1_2_7_1_17_1
  doi: 10.1186/1741-7015-10-39
– ident: e_1_2_7_1_5_1
  doi: 10.1038/nature11928
– ident: e_1_2_7_1_9_1
  doi: 10.1016/j.bbrc.2018.06.089
– ident: e_1_2_7_1_23_1
  doi: 10.1016/j.canlet.2018.02.014
– volume: 22
  start-page: 118
  year: 2018
  ident: e_1_2_7_1_14_1
  article-title: Silencing of hsa_circ_0007534 suppresses proliferation and induces apoptosis in colorectal cancer cells
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Zhang R
– ident: e_1_2_7_1_26_1
  doi: 10.1159/000491468
– ident: e_1_2_7_1_19_1
  doi: 10.5582/irdr.2018.01013
– ident: e_1_2_7_1_10_1
  doi: 10.1016/j.bbrc.2018.05.174
– ident: e_1_2_7_1_11_1
  doi: 10.2147/OTT.S150678
– ident: e_1_2_7_1_6_1
  doi: 10.1261/rna.035667.112
– ident: e_1_2_7_1_24_1
  doi: 10.2147/OTT.S150678
– ident: e_1_2_7_1_28_1
  doi: 10.18632/oncotarget.14710
– ident: e_1_2_7_1_12_1
  doi: 10.1016/j.canlet.2018.02.014
– ident: e_1_2_7_1_21_1
  doi: 10.1016/j.yexcr.2018.05.002
– ident: e_1_2_7_1_4_1
  doi: 10.1002/jso.24623
– ident: e_1_2_7_1_18_1
  doi: 10.3390/genes8120353
– ident: e_1_2_7_1_25_1
  doi: 10.2147/OTT.S132558
– volume: 7
  start-page: 1835
  year: 2017
  ident: e_1_2_7_1_27_1
  article-title: MicroRNA‐625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2
  publication-title: Am J Cancer Res
  contributor:
    fullname: Zhang J
– ident: e_1_2_7_1_8_1
  doi: 10.1016/j.bbrc.2018.01.077
SSID ssj0009932
Score 2.5854511
Snippet Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including pancreatic...
Abstract Circular RNAs (circRNAs) have been regarded as critical regulators of human diseases and biological markers in some types of malignancies, including...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 3780
SubjectTerms Adenocarcinoma
Apoptosis
Assaying
Biomarkers
Biotechnology
Caspase
Cell growth
Cell migration
Cell proliferation
circ_0007534
Circular RNA
Invasiveness
Lymph nodes
Metastases
miR‐625
miR‐892b
Pancreas
Pancreatic cancer
pancreatic ductal adenocarcinoma
Polymerase chain reaction
Regulators
Ribonucleic acid
RNA
Tissues
Xenografts
Xenotransplantation
Title Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR‐625 and miR‐892b
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcb.27658
https://www.ncbi.nlm.nih.gov/pubmed/30382592
https://www.proquest.com/docview/2167055798/abstract/
https://search.proquest.com/docview/2127952188
Volume 120
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEBYhUNpL26R_2yZBLT30EG_Wsi1b9JQsDSHQHJYu5FAw-gWnibysdwPpqY_Q9-pb9Ek6I603pKVQerPQyJKtkeYba_wNIW_TkSkzVfBEpU4lYG_zpEpTl5jCGa2cFkLjv8Mfz_jJND89L843yPv-X5jID7H-4IYrI-zXuMCl6g5uSUMvtBqyEgwo7L9IpIeAaHJLHQV2N5wggAYngGFYzyo0Ygfrlndt0R8A8y5eDQbn-BH53A81xpl8GS4Xaqi__sbi-J_P8pg8XAFRehg1Z4tsWL9N7sXUlDfb5P64zwT3hPyYzuYxZb01VDfzELpKJ2eHoVAHQJDlFE-_Mb6qo9LTpXfyGtRLXVqKMWC-7ZoORCjsPhGoaopUszAECVsfWNS5bnx7JaGxoX13HcWDBbzBJYbgBC3ap3LWzhZ4v_0g3Phrid_8qLqhGPCLaZfoVTP5-e07uF1BJJYqwdRTMj3-8Gl8kqySQCQ6T0UFFrRQXMsilYIDlFGFyaQCvws8d5nqzBQZqwwAD3R9ZJVyrUd4kjvizjpZQfUzsulbb18Qykueq7zIeMZ0boWuyswwZ5VUrihV7gbkTa8O9SxyfdSR1ZnVMEN1mKEB2ekVpV4t965mKUdWolJA9et1NcwSviTpbbtEGVYKAEsVyDyPCrbuBXAEeOqCDci7oCZ_774-HR-Fi5f_LvqKPACYJ2Lk3A7ZXMyXdheg1ELthTXzC4PhHMQ
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BbtQwELVKESqXFgqlSwsYxIFDs904sRNLXMqKaintHlZdqRcU2U4sBdpktdmtVE58Av_Vv-iXMGNvtioICXFL5EmcxDOeN_bkDSFvw16eRJqLQIdWB-Bv4yANQxvk3OZGWyOlwX-HT4ZiMI6PzvjZCnnf_gvj-SGWC25oGW6-RgPHBen9W9bQr0Z3WQIe9B65D-bOXUA1uiWPAs_r9hBAhwNAMazlFeqx_eWld73RHxDzLmJ1Ludwg3xpH9Znmnzrzme6a77_xuP4v2_ziKwvsCg98MrzmKwU1SZ54KtTXm2StX5bDO4JuR5Ppr5qfZFTU05d9iodDQ_cSeYwQRRT3ADHFKuGqorOK6suQcP0eUExDayqm7IBEQoTkMeqhiLbLDyCgtkPnOrUlFV9oeDinLbdNRT3FvAG55iF4xRpj6pJPZnh_faccFldKlz2o_qKYs4vVl6iF-Xo5sdPiLyciD9LJdNPyfjw42l_ECzqQAQmDmUKTpRrYRQPlRSAZjTPI6Uh9ILgXYUmynnE0hywB0Y_Kg2FMT3czO0JW1iVQvMWWa3qqtgmVCQi1jGPRMRMXEiTJlHObKGVtjzRse2QN60-ZBNP95F5YmeWwQhlboQ6ZLfVlGxh8U3GQoHERImE5tfLZhgl_EiqKuo5yrBEAl5KQeaZ17BlLwAlIFiXrEPeOT35e_fZUf-DO3j-76KvyNrg9OQ4O_40_LxDHgLqkz6Rbpeszqbz4gUgq5l-6QzoF0aWIOY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbGED83_AwYhQEGccHF0jVO4sTianRUY0CFKirtYlLkn1gK25KoaSeNKx6B9-IteBLOsZtOAyEh7hr5JE7qzz7fiU--Q8jLcGDSSCU8UKFVAfjbOMjC0AYmsUYrq4XQ-O3wxzHfn8YHh8nhGnndfQvj9SFWL9xwZrj1Gid4Y-zOhWjoF636LAUHeoVcjXnEENJ7kwvtKHC8bgsBIBwAiWGdrNCA7axOveyM_mCYlwmr8zij2-Sou1efaHLcX8xVX3_9TcbxPx_mDrm1ZKJ010PnLlkrqg1yzdemPN8gN4ZdKbh75Me0mfma9YWhupy53FU6Ge-6g9wxgiimuP2NCVYtlRVdVFaeAb7USUExCayq27IFEwrLj2eqmqLWLNyChLUPXOpMl1V9KuFkQ7vuWoo7C3iBE8zBcTDaprKpmzleb9sZl9WZxJd-VJ1TzPjFukv0tJz8_PYd4i5n4o8ywdR9Mh29_TzcD5ZVIAIdhyIDF5oormUSSsGBy6jERFJB4AWhuwx1ZJKIZQaYB8Y-Mgu51gPcyh1wW1iZQfMDsl7VVfGQUJ7yWMVJBGjRcSF0lkaG2UJJZZNUxbZHXnRwyBsv9pF7WWeWwwjlboR6ZKsDSr6c723OQo6yRKmA5uerZhgl_JNkVdQLtGGpALaUgc2mB9iqFyASEKoL1iOvHEz-3n1-MHzjfjz6d9Nn5PqnvVH-4d34_WNyEyif8Fl0W2R9PlsUT4BWzdVTN31-AdR1H5U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulated+circular+RNA+circ_0007534+indicates+an+unfavorable+prognosis+in+pancreatic+ductal+adenocarcinoma+and+regulates+cell+proliferation%2C+apoptosis%2C+and+invasion+by+sponging+miR%E2%80%90625+and+miR%E2%80%90892b&rft.jtitle=Journal+of+cellular+biochemistry&rft.au=Hao%2C+Liguo&rft.au=Rong%2C+Wei&rft.au=Bai%2C+Lianjie&rft.au=Cui%2C+Hongsheng&rft.date=2019-03-01&rft.issn=0730-2312&rft.eissn=1097-4644&rft.volume=120&rft.issue=3&rft.spage=3780&rft.epage=3789&rft_id=info:doi/10.1002%2Fjcb.27658&rft.externalDBID=10.1002%252Fjcb.27658&rft.externalDocID=JCB27658
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-2312&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-2312&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-2312&client=summon